289 related articles for article (PubMed ID: 25445449)
1. Biomechanical properties of bone in a mouse model of Rett syndrome.
Kamal B; Russell D; Payne A; Constante D; Tanner KE; Isaksson H; Mathavan N; Cobb SR
Bone; 2015 Feb; 71():106-14. PubMed ID: 25445449
[TBL] [Abstract][Full Text] [Related]
2. Mecp2 deficiency decreases bone formation and reduces bone volume in a rodent model of Rett syndrome.
O'Connor RD; Zayzafoon M; Farach-Carson MC; Schanen NC
Bone; 2009 Aug; 45(2):346-56. PubMed ID: 19414073
[TBL] [Abstract][Full Text] [Related]
3. Osteoblast function and bone histomorphometry in a murine model of Rett syndrome.
Blue ME; Boskey AL; Doty SB; Fedarko NS; Hossain MA; Shapiro JR
Bone; 2015 Jul; 76():23-30. PubMed ID: 25769649
[TBL] [Abstract][Full Text] [Related]
4. Zoledronic acid improves bone histomorphometry in a murine model of Rett syndrome.
Shapiro JR; Boskey AL; Doty SB; Lukashova L; Blue ME
Bone; 2017 Jun; 99():1-7. PubMed ID: 28323142
[TBL] [Abstract][Full Text] [Related]
5. Wild-type microglia arrest pathology in a mouse model of Rett syndrome.
Derecki NC; Cronk JC; Lu Z; Xu E; Abbott SB; Guyenet PG; Kipnis J
Nature; 2012 Mar; 484(7392):105-9. PubMed ID: 22425995
[TBL] [Abstract][Full Text] [Related]
6. Methyl-CpG-binding protein 2 (MECP2) mutation type is associated with bone disease severity in Rett syndrome.
Caffarelli C; Gonnelli S; Pitinca MDT; Camarri S; Al Refaie A; Hayek J; Nuti R
BMC Med Genet; 2020 Jan; 21(1):21. PubMed ID: 32005172
[TBL] [Abstract][Full Text] [Related]
7. DXA measurements in Rett syndrome reveal small bones with low bone mass.
Roende G; Ravn K; Fuglsang K; Andersen H; Nielsen JB; Brøndum-Nielsen K; Jensen JE
J Bone Miner Res; 2011 Sep; 26(9):2280-6. PubMed ID: 21590733
[TBL] [Abstract][Full Text] [Related]
8. Pharmacological reactivation of inactive X-linked
Przanowski P; Wasko U; Zheng Z; Yu J; Sherman R; Zhu LJ; McConnell MJ; Tushir-Singh J; Green MR; Bhatnagar S
Proc Natl Acad Sci U S A; 2018 Jul; 115(31):7991-7996. PubMed ID: 30012595
[TBL] [Abstract][Full Text] [Related]
9. Exploring the possible link between MeCP2 and oxidative stress in Rett syndrome.
Filosa S; Pecorelli A; D'Esposito M; Valacchi G; Hajek J
Free Radic Biol Med; 2015 Nov; 88(Pt A):81-90. PubMed ID: 25960047
[TBL] [Abstract][Full Text] [Related]
10. A codon-optimized Mecp2 transgene corrects breathing deficits and improves survival in a mouse model of Rett syndrome.
Matagne V; Ehinger Y; Saidi L; Borges-Correia A; Barkats M; Bartoli M; Villard L; Roux JC
Neurobiol Dis; 2017 Mar; 99():1-11. PubMed ID: 27974239
[TBL] [Abstract][Full Text] [Related]
11. Metabolic fingerprints of altered brain growth, osmoregulation and neurotransmission in a Rett syndrome model.
Viola A; Saywell V; Villard L; Cozzone PJ; Lutz NW
PLoS One; 2007 Jan; 2(1):e157. PubMed ID: 17237885
[TBL] [Abstract][Full Text] [Related]
12. Astrocyte Transcriptome from the Mecp2(308)-Truncated Mouse Model of Rett Syndrome.
Delépine C; Nectoux J; Letourneur F; Baud V; Chelly J; Billuart P; Bienvenu T
Neuromolecular Med; 2015 Dec; 17(4):353-63. PubMed ID: 26208914
[TBL] [Abstract][Full Text] [Related]
13. Synaptic plasticity deficits in an experimental model of rett syndrome: long-term potentiation saturation and its pharmacological reversal.
Weng SM; McLeod F; Bailey ME; Cobb SR
Neuroscience; 2011 Apr; 180():314-21. PubMed ID: 21296130
[TBL] [Abstract][Full Text] [Related]
14. Temporal shift in methyl-CpG binding protein 2 expression in a mouse model of Rett syndrome.
Metcalf BM; Mullaney BC; Johnston MV; Blue ME
Neuroscience; 2006; 139(4):1449-60. PubMed ID: 16549272
[TBL] [Abstract][Full Text] [Related]
15. Defects in brainstem neurons associated with breathing and motor function in the Mecp2R168X/Y mouse model of Rett syndrome.
Johnson CM; Zhong W; Cui N; Wu Y; Xing H; Zhang S; Jiang C
Am J Physiol Cell Physiol; 2016 Dec; 311(6):C895-C909. PubMed ID: 27653984
[TBL] [Abstract][Full Text] [Related]
16. Morphological and functional alterations in the substantia nigra pars compacta of the Mecp2-null mouse.
Panayotis N; Pratte M; Borges-Correia A; Ghata A; Villard L; Roux JC
Neurobiol Dis; 2011 Feb; 41(2):385-97. PubMed ID: 20951208
[TBL] [Abstract][Full Text] [Related]
17. Disruption of MeCP2 attenuates circadian rhythm in CRISPR/Cas9-based Rett syndrome model mouse.
Tsuchiya Y; Minami Y; Umemura Y; Watanabe H; Ono D; Nakamura W; Takahashi T; Honma S; Kondoh G; Matsuishi T; Yagita K
Genes Cells; 2015 Dec; 20(12):992-1005. PubMed ID: 26456390
[TBL] [Abstract][Full Text] [Related]
18. Brain protein changes in Mecp2 mouse mutant models: Effects on disease progression of Mecp2 brain specific gene reactivation.
Cortelazzo A; De Felice C; Guy J; Timperio AM; Zolla L; Guerranti R; Leoncini S; Signorini C; Durand T; Hayek J
J Proteomics; 2020 Jan; 210():103537. PubMed ID: 31629059
[TBL] [Abstract][Full Text] [Related]
19. Progressive Changes in a Distributed Neural Circuit Underlie Breathing Abnormalities in Mice Lacking MeCP2.
Huang TW; Kochukov MY; Ward CS; Merritt J; Thomas K; Nguyen T; Arenkiel BR; Neul JL
J Neurosci; 2016 May; 36(20):5572-86. PubMed ID: 27194336
[TBL] [Abstract][Full Text] [Related]
20. Separate respiratory phenotypes in methyl-CpG-binding protein 2 (Mecp2) deficient mice.
Bissonnette JM; Knopp SJ
Pediatr Res; 2006 Apr; 59(4 Pt 1):513-8. PubMed ID: 16549521
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
